nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma
|
AbuRuz, S. |
|
2007 |
|
1 |
p. 110-115 |
artikel |
2 |
Age-related differences in the pharmacokinetics of stavudine in 272 children from birth to 16 years: a population analysis
|
Jullien, V. |
|
2007 |
|
1 |
p. 105-109 |
artikel |
3 |
Altered deoxyuridine and thymidine in plasma following capecitabine treatment in colorectal cancer patients
|
Li, Kong M. |
|
2007 |
|
1 |
p. 67-74 |
artikel |
4 |
Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea
|
Praharaj, Samir K. |
|
2007 |
|
1 |
p. 128-129 |
artikel |
5 |
A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilation
|
Conil, Jean Marie |
|
2007 |
|
1 |
p. 27-35 |
artikel |
6 |
Assessment of the validity of a population pharmacokinetic model for epirubicin
|
Ralph, Lorraine D. |
|
2006 |
|
1 |
p. 47-55 |
artikel |
7 |
Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey
|
Stewart, Derek |
|
2007 |
|
1 |
p. 90-95 |
artikel |
8 |
Brain histamine H1 receptor occupancy of orally administered antihistamines measured by positron emission tomography with 11C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen
|
Tashiro, Manabu |
|
2006 |
|
1 |
p. 16-26 |
artikel |
9 |
Cancer pharmacotherapy: 21st century ‘magic bullets’ and changing paradigms
|
Lewis, L. D. |
|
2006 |
|
1 |
p. 1-4 |
artikel |
10 |
Comparative bioequivalence study between a novel matrix transdermal delivery system of fentanyl and a commercially available reservoir formulation
|
Marier, Jean-Francois |
|
2007 |
|
1 |
p. 121-124 |
artikel |
11 |
Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy
|
van Zanten, A. R. H. |
|
2007 |
|
1 |
p. 100-109 |
artikel |
12 |
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients
|
Joerger, M. |
|
2006 |
|
1 |
p. 71-80 |
artikel |
13 |
Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain?
|
Hughes, Jeff |
|
2007 |
|
1 |
p. 83-89 |
artikel |
14 |
Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain
|
Forst, Thomas |
|
2007 |
|
1 |
p. 75-82 |
artikel |
15 |
Drug development in oncology: classical cytotoxics and molecularly targeted agents
|
Kummar, Shivaani |
|
2006 |
|
1 |
p. 15-26 |
artikel |
16 |
Editors’ review of 2006 and the BJCP prize
|
Aronson, Jeffrey K |
|
2007 |
|
1 |
p. 1-4 |
artikel |
17 |
Education for new prescribers: a summary of the proceedings of a symposium held at The British Pharmacological Society, December 2005
|
Leathard, Helen L. |
|
2007 |
|
1 |
p. 5-9 |
artikel |
18 |
Effect of ABCB1 (MDR1) haplotypes derived from G2677T/C3435T on the pharmacokinetics of amlodipine in healthy subjects
|
Kim, Kyoung-Ah |
|
2007 |
|
1 |
p. 53-58 |
artikel |
19 |
Effect of rifampicin on the pharmacokinetics of pioglitazone
|
Jaakkola, Tiina |
|
2006 |
|
1 |
p. 70-78 |
artikel |
20 |
Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects
|
Saari, Teijo I. |
|
2007 |
|
1 |
p. 116-120 |
artikel |
21 |
Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics
|
Grimm, Scott W. |
|
2006 |
|
1 |
p. 58-69 |
artikel |
22 |
Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokinetics
|
Forgue, S. Thomas |
|
2007 |
|
1 |
p. 24-35 |
artikel |
23 |
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene
|
Ouellet, D. |
|
2007 |
|
1 |
p. 59-66 |
artikel |
24 |
Erratum
|
|
|
2006 |
|
1 |
p. 114 |
artikel |
25 |
Erratum
|
|
|
2007 |
|
1 |
p. 118 |
artikel |
26 |
Establishing a baseline for the monitoring of medicines availability for children in the UK: 1998–2002
|
Balakrishnan, Komathi |
|
2007 |
|
1 |
p. 85-91 |
artikel |
27 |
Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation
|
Brunner, M. |
|
2006 |
|
1 |
p. 31-38 |
artikel |
28 |
Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia
|
Tang, Yi-lang |
|
2007 |
|
1 |
p. 49-56 |
artikel |
29 |
Glimepiride-induced vasculitis: a case report
|
Ben Salem, Chaker |
|
2007 |
|
1 |
p. 113-114 |
artikel |
30 |
Incidental events in spontaneous reports – a proposal for filtering ’noise’
|
Walsh, Louisa |
|
2006 |
|
1 |
p. 118-119 |
artikel |
31 |
Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects
|
Zhang, Yifan |
|
2007 |
|
1 |
p. 67-74 |
artikel |
32 |
John Trounce
|
Spector, Roy G. |
|
2007 |
|
1 |
p. 116-117 |
artikel |
33 |
Limited predictability of amikacin clearance in extreme premature neonates at birth
|
Allegaert, Karel |
|
2006 |
|
1 |
p. 39-48 |
artikel |
34 |
Long-term effects of an educational intervention on self-medication and appropriate drug use in single-sex secondary public schools, Quito, Ecuador
|
Maldonado, Juan-Carlos |
|
2007 |
|
1 |
p. 92-99 |
artikel |
35 |
N-acetylcysteine – passe-partout or much ado about nothing?
|
Aitio, Mirja-Liisa |
|
2006 |
|
1 |
p. 5-15 |
artikel |
36 |
New targets and challenges in the molecular therapeutics of cancer
|
Eastman, Alan |
|
2006 |
|
1 |
p. 5-14 |
artikel |
37 |
No association between CYP2D6 polymorphisms and personality trait in Japanese
|
Iwashima, Kumiko |
|
2007 |
|
1 |
p. 96-99 |
artikel |
38 |
Off-label and unlicensed prescribing for children: have we made any progress?
|
Waller, D. G. |
|
2007 |
|
1 |
p. 1-2 |
artikel |
39 |
µ-Opiate receptor agonists – a new pharmacological approach to prevent motion sickness?
|
Otto, Bärbel |
|
2006 |
|
1 |
p. 27-30 |
artikel |
40 |
Oxford Handbook of Nurse Prescribing
|
|
|
2007 |
|
1 |
p. 115 |
artikel |
41 |
Paracetamol use and risk of ovarian cancer: a meta-analysis
|
Bonovas, Stefanos |
|
2006 |
|
1 |
p. 113-121 |
artikel |
42 |
Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or β-blockers and the risk of atherosclerosis
|
Schelleman, H. |
|
2007 |
|
1 |
p. 57-66 |
artikel |
43 |
Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion
|
Fidler, Meredith C. |
|
2007 |
|
1 |
p. 36-40 |
artikel |
44 |
Pharmacokinetics, safety and tolerance of single- and multiple-dose adefovir dipivoxil in healthy Chinese subjects
|
Sun, De-qing |
|
2007 |
|
1 |
p. 15-23 |
artikel |
45 |
Population analysis of a 24-h paclitaxel infusion in advanced endometrial cancer: a gynaecological oncology group study
|
Mould, Diane R. |
|
2006 |
|
1 |
p. 56-70 |
artikel |
46 |
Population pharmacokinetic and pharmacodynamic models of remifentanil in healthy volunteers using artificial neural network analysis
|
Kang, S. H. |
|
2007 |
|
1 |
p. 3-13 |
artikel |
47 |
Population pharmacokinetic modelling of NS2330 (tesofensine) and its major metabolite in patients with Alzheimer's disease
|
Lehr, Thorsten |
|
2007 |
|
1 |
p. 36-48 |
artikel |
48 |
Population pharmacokinetics of darbepoetin alfa in healthy subjects
|
Agoram, Balaji |
|
2007 |
|
1 |
p. 41-52 |
artikel |
49 |
Population pharmacokinetics of imatinib and the role of α1-acid glycoprotein
|
Widmer, N. |
|
2006 |
|
1 |
p. 97-112 |
artikel |
50 |
Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients
|
Perez-Ruixo, Juan Jose |
|
2006 |
|
1 |
p. 81-96 |
artikel |
51 |
Quantification of infant exposure to celecoxib through breast milk
|
Gardiner, Sharon J. |
|
2006 |
|
1 |
p. 101-104 |
artikel |
52 |
Recent developments in the clinical pharmacology of classical cytotoxic chemotherapy
|
Boddy, Alan V. |
|
2006 |
|
1 |
p. 27-34 |
artikel |
53 |
Regional variations in community consumption of antibiotics in Hungary, 1996–2003
|
Matuz, Maria |
|
2006 |
|
1 |
p. 96-100 |
artikel |
54 |
Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance
|
Theunissen, Eef L. |
|
2006 |
|
1 |
p. 79-86 |
artikel |
55 |
Reply: The evaluation of data mining methods for the simultaneous and systematic detection of safety signals in large databases: lessons to be learned
|
Levine, Jonathan G. |
|
2006 |
|
1 |
p. 105-113 |
artikel |
56 |
Response to letter by Levine et al.
|
Hauben, Manfred |
|
2006 |
|
1 |
p. 115-117 |
artikel |
57 |
Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region
|
Chinellato, Alessandro |
|
2006 |
|
1 |
p. 130-133 |
artikel |
58 |
Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation
|
Moreno, Raul |
|
2007 |
|
1 |
p. 110-112 |
artikel |
59 |
Statins down under
|
Mant, Andrea |
|
2007 |
|
1 |
p. 125-127 |
artikel |
60 |
Substitution of phenylephrine for pseudoephedrine as a nasal decongeststant. An illogical way to control methamphetamine abuse
|
Eccles, Ronald |
|
2007 |
|
1 |
p. 10-14 |
artikel |
61 |
The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide
|
Bidstrup, Tanja Busk |
|
2006 |
|
1 |
p. 49-57 |
artikel |
62 |
The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and β-glucuronidase in human colorectal tumours
|
Tobin, Peter |
|
2006 |
|
1 |
p. 122-129 |
artikel |
63 |
The role of pharmacogenetics in cancer therapeutics
|
Yong, Wei Peng |
|
2006 |
|
1 |
p. 35-46 |
artikel |
64 |
The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies –CYP2C9 and warfarin as an example
|
Dickinson, Gemma L. |
|
2007 |
|
1 |
p. 14-26 |
artikel |
65 |
Thiazide diuretic prescription and electrolyte abnormalities in primary care
|
Clayton, J. A. |
|
2006 |
|
1 |
p. 87-95 |
artikel |
66 |
Today's science, tomorrow's medicines
|
Aronson, Jeffrey K. |
|
2006 |
|
1 |
p. 1-4 |
artikel |
67 |
Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes
|
Roughead, Elizabeth E. |
|
2007 |
|
1 |
p. 100-104 |
artikel |
68 |
Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance
|
Anderson, Brian J. |
|
2007 |
|
1 |
p. 75-84 |
artikel |